Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP316701.RAg7neFoUUu_ePdpZJDGYfEVIaFYGFOfjIqN41XIy4fbg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP316701.RAg7neFoUUu_ePdpZJDGYfEVIaFYGFOfjIqN41XIy4fbg130_assertion type Assertion NP316701.RAg7neFoUUu_ePdpZJDGYfEVIaFYGFOfjIqN41XIy4fbg130_head.
- NP316701.RAg7neFoUUu_ePdpZJDGYfEVIaFYGFOfjIqN41XIy4fbg130_assertion description "[Within high-grade MEC, MECT1/MAML2 positive tumors had lower rates of anaplasia (P=0.001), and mitotic counts (P=0.012).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP316701.RAg7neFoUUu_ePdpZJDGYfEVIaFYGFOfjIqN41XIy4fbg130_provenance.
- NP316701.RAg7neFoUUu_ePdpZJDGYfEVIaFYGFOfjIqN41XIy4fbg130_assertion evidence source_evidence_literature NP316701.RAg7neFoUUu_ePdpZJDGYfEVIaFYGFOfjIqN41XIy4fbg130_provenance.
- NP316701.RAg7neFoUUu_ePdpZJDGYfEVIaFYGFOfjIqN41XIy4fbg130_assertion SIO_000772 20588178 NP316701.RAg7neFoUUu_ePdpZJDGYfEVIaFYGFOfjIqN41XIy4fbg130_provenance.
- NP316701.RAg7neFoUUu_ePdpZJDGYfEVIaFYGFOfjIqN41XIy4fbg130_assertion wasDerivedFrom befree-20140225 NP316701.RAg7neFoUUu_ePdpZJDGYfEVIaFYGFOfjIqN41XIy4fbg130_provenance.
- NP316701.RAg7neFoUUu_ePdpZJDGYfEVIaFYGFOfjIqN41XIy4fbg130_assertion wasGeneratedBy ECO_0000203 NP316701.RAg7neFoUUu_ePdpZJDGYfEVIaFYGFOfjIqN41XIy4fbg130_provenance.